Abstract
Introduction
Activation of ^-adrenoceptors may inhibit the release of mediators like histamine [1] ; (3-sympathomimetic drugs are most effective in relieving acute shortness of breath in bronchial asthma [2] . In agreement with these observations, Szentivanyi [3] suggested that a subsensitivity of (> adrenergic receptors due to a disturbance of their expression and/or function may be related to the pathophysiology of atopic bronchial asthma. Further reports have indicated a subsensitivity of (3-adrenoceptors also in other atopic diseases [4, 5] .
Usually either the expression of (^-adrenoceptors or their function has been investigated in studies on the (3-adrenergic system in atopic disease. However, to fully describe receptors pharmacologically, both aspects have to be evaluated. We recently reported a decreased affinity of PBL (^-adrenoceptors in atopic bronchial asthma that was correlated with the stimulation of the intracellular formation of cyclic adenosine monophosphate (cAMP) by isoprenaline [6] . We have now investigated atopic patients with seasonal allergic rhinoconjunctivitis during the acute phase of their disease.
Materials and Methods
Patients and Controls 20 ml of venous blood was drawn from the antecubital vein of 7 healthy women (21-51 years of age) and 7 atopic women suffering from seasonal allergic rhinoconjunctivitis (22^42 years of age). All samples were taken between 0830 and 09.30 h in the morning to avoid that the results were influenced by circadian variations [7] . The study was performed in April/May. All subjects had a negative history and showed no signs of pulmonary, cardiac, renal, and hepatic disease, nor of any other disease by clinical inspection. No drugs were taken.
The patients had a history of seasonal rhinoconjunctivitis (AprilAugust) for 4-20 years. They had no personal history of perennial rhinoconjunctivitis and no personal or family history of any other atopic disease (asthma, atopic eczema). Allergy to the relevant allergens (birch or grass pollen) had been adequately demonstrated (prick test, radioallergosorbent test). The investigations started in the pollen season after symptoms had been present for at least 3 days.
Antiallergic drugs had not yet been taken.
The healthy subjects had no personal or family history of allergic rhinoconjunctivitis and/or any other atopic disease (asthma, atopic eczema) and showed no skin prick reactions to house dust mite, cat epithelia, nor to grass pollen. 
Methods
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Results
No significant differences were observed in the B max values of patients (1,607±94 l25 I-CYP-binding sites/cell) and controls (1,863±248 125 I-CYP-binding sites/cell; fig. I  top panel) . K d , however, was increased in the atopic patients (6.4±1.0 vs. 3.4±0.6 pmol/1 in controls; p<0.05), indicating a decreased affinity of the adrenergic radioligand for its binding site ( fig. 1, bottom panel) .
Eo of leukocytes obtained from the atopic patients (4.9±0.8 pmol/10 6 cells) was significantly lower than in the healthy subjects (8 145±8% Eo in controls; p<0.01; fig. 2 , middle panel). EC 50 was higher in the atopic patients than in the healthy subjects (1,088.6±669.0 vs. 71.0±5L0 nmol/1; p<0.01; fig. 2 , bottom panel), indicating a reduced sensitivity of (^-adrenoceptors to [3-adrenergic stimuli. The cAMP plasma concentrations were decreased in the atopic patients, too (25.7±1.2 nmol/1 in patients vs. 31.3±1.6 nmol/1 in controls; p<0.05; fig. 3 ).
Discussion
The results point to an altered expression and function of ^-adrenoceptors on PBL in patients with seasonal rhinoconjunctivitis. Compared to controls, the results demonstrate three features of the PBL |3 2 -adrenoceptor/ cAMP system that are compatible with 'subsensitivity of ^-adrenoceptors PBL in atopic disease: (1) a reduced affinity of the (3-adrenergic radioligand to its binding site (K d ); (2) a reduced sensitivity of the intracellular cAMP formation to (3-adrenergic stimuli (EC 50 ), and (3) a reduced intracellular cAMP increase in response to isoprenaline (E max expressed as a percentage of E 0 ). Correspondingly, cAMP plasma concentrations, a general marker for the sympathetic tone, were found reduced as well.
However, subsensitivity of (^-adrenoceptors does not sufficiently explain the reduced basal cAMP content of the cells. The basal cAMP content reflects the steady state between intracellular formation and degradation of cAMP. Besides decreased formation of cAMP, an increased activity of the cAMP-degrading enzyme phosphodiesterase would, therefore, result in a reduced basal cAMP content, too. Such an increased phosphodiesterase activity had been suggested by Grewe et al. [9] . More than just one mechanism seems to be involved in the impairment of the PBL (3 2 -adrenoceptor/cAMP system in atopy.
Regardless whether the impairment of the PBL p,-adrenoceptor/cAMP system in atopic seasonal rhinoconjunctivitis is primary or secondary due to disease, it may be pathophysiological^ relevant. Further work is under way in order to elucidate possible changes in the reported variables during and out of the symptomatic season.
